Indexed with PubMed and Science Citation Index (E) 
Users online: 3923 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE here  
     Current Issue
     Submit Article 
     My Preferences 
     Dermatology crossword 


This article has been cited by
1Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
Alessia Villani,Gabriella Fabbrocini,Claudia Costa,Massimiliano Scalvenzi
Dermatology and Therapy.2020;10(3)401
2Long-Term Efficacy of Vismodegib After its Withdrawal and Patientsí Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)
Alessia Villani,Matteo Megna,Gabriella Fabbrocini,Milena Cappello,Maria Antonietta Luciano,Claudia Costa,Massimiliano Scalvenzi
Dermatology and Therapy.2019;9(4)719
3Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
Massimiliano Scalvenzi,Milena Cappello,Claudia Costa,Gabriella Fabbrocini,Mariaantonietta Luciano,Alessia Villani
Dermatology and Therapy.2020;10(3)465
4Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
Alessia Villani,Gabriella Fabbrocini,Milena Cappello,Claudia Costa,Massimiliano Scalvenzi
Dermatology and Therapy.2019;9(3)505
Alessia Villani,Gabriella Fabbrocini,Milena Cappello,Claudia Costa,Massimiliano Scalvenzi
Reactions Weekly.2018;1729(1)265
6The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients
A. Villani,C. Costa,M. Cappello,G. Fabbrocini,M. Scalvenzi
Journal of Dermatological Treatment.2020;1729(1)1
7Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience
Massimiliano Scalvenzi,Alessia Villani,Claudia Costa,Milena Cappello
Dermatologic Therapy.2019;1729(1)e12971
8Orbito-scleral-sinus invasion of basal cell carcinoma in an immunocompromised patient on vismodegib
Ann Q. Tran,Carissa L. Patete,Nathan W. Blessing,Andrew J. Rong,Armando L. Garcia,Sander Dubovy,David T. Tse
Online since 15th March '04
Published by Wolters Kluwer - Medknow